Speakers

Christophe Queva

CSO

Oncorus

Nigel Pheasey

Director, Process Development

Amgen

Natalia Ulyanova

Director Oncology Business Development

Astellas Pharma

Natalie Roy D’Amore

Director, Partnerships

Takeda Oncology

Paola Grandi

CSO

CG Oncology

Sharad Sharma

Principal Scientist, NBE Pharmacokinetics

Boehringer Ingelheim

Erik Wiklund

CBO

Targovax

Jeffrey Bockman

EVP, Oncology Practice Head

Cello Health BioConsulting

Keri Streby

Assistant Professor Pediatric Oncology

Nationwide Children’s Hospital

Steve Thorne

CSO

Western Oncolytics

William Jia

CSO

Virogin

Xiaotong Song

Assistant Professor, Center for Cell and Gene Therapy

Baylor College of Medicine

Agnieszka Denslow

Principal Scientist, In Vivo Pharmacology

Oncorus

Angelica Loskog

CSO

Lokon Pharma

Antonio Chiocca

Neurosurgeon-in- Chief and Chairman, Department of Neurosurgery

Brigham & Women’s Hospital

Gregory Friedman

Associate Professor, Division of Pediatric Hematology-Oncology

The University of Alabama at Birmingham

Hiroaki Wakimoto

Associate Professor, Neurosurgery

Massachusetts General Hospital

Sean Lawler

Assistant Professor, Neurosurgery

Brigham And Women’s Hospital

Balveen Kaur

Professor, Vice Chair Research MD Andersen Cancer Center

The University of Texas

Carolina Ilkow

Assistant Professor

The Ottawa Hospital Research Institute

Caroline Breitbach

VP R&D Programs and Strategy

Turnstone Biologics

Hideki Kasuya

Professor, Cancer Immune Therapy

Nagoya University

Khalid Shah

Vice Chair of Research

Brigham And Women’s Hospital

Robert Coffin

CEO

Replimune

Johanna Kaufmann

EVP Oncology

Codagenix

Emily Wilkinson

Research Analyst

Beacon Targeted Therapies

Gregory Kavalerov

Account Manager

Beacon Targeted Therapies